bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.07.08.737160

Comparison of localGEBV and Optimal Haplotype Stacking Fitness Functions using a Novel R Package: HapSelect

Abstract

Haplotype-based breeding strategies have emerged as promising approaches to maximize long-term genetic gain by identifying complementary parental combinations while maintaining genetic diversity. However, these methods typically require phased genotypes and more intensive workflow pipelines and skillsets. We developed a novel local genomic estimated breeding value (localGEBV) fitness function with similar intent to the optimal haplotype stacking (OHS) framework fitness function and implemented both in the novel R package, HapSelect. Our aim was to evaluate whether phased haplotypes provide additional benefit over the more easily available dosage-based unphased genotypes in highly inbred crops. A subset of bread wheat nested association mapping (NAM) population comprising 444 lines genotyped with 6,054 DArT-Seq markers was analysed. Marker effects were estimated using rrBLUP, localGEBV and haplotype effects were calculated across linkage disequilibrium-defined haploblocks, and genetic algorithms (GA) were used to identify optimal sets of 30 founders using either a localGEBV derived fitness function with unphased, dosage inputs or the OHS fitness function with phased inputs. Selected parental sets were compared with conventional truncation selection (TS) through 150 generations of forward simulation. The OHS fitness function achieved a marginally greater optimized ultimate GEBV than the localGEBV fitness function during GA optimization, with only 18 of the 30 selected founders overlapped between the two methods. Despite these differences, forward simulations demonstrated nearly identical long-term genetic gain for localGEBV and OHS-selected founders, with both approaches outperforming conventional truncation selection by maintaining greater genetic diversity and delaying the genetic plateau. The minimal difference between localGEBV and OHS is likely attributable to the high homozygosity of the population, where localGEBV and haplotype effects are nearly confounded. These results demonstrate that dosage-based localGEBV provides a practical alternative to phased haplotype approaches for parent selection in inbred crops, substantially simplifying genomic workflows while maintaining long-term breeding performance. Future work should evaluate these methods in more diverse inbred populations and outbred species, where great haplotypic diversity may increase the advantage of true haplotype-based optimizations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Shaffer, W., Papin, V., Carter, Z., Brunner, S. M., Tong, J., Villiers, K., Robinson, H., Voss-Fels, K., Hayes, B. J., Hickey, L., Dinglasan, E.. 2026-07-13. Comparison of localGEBV and Optimal Haplotype Stacking Fitness Functions using a Novel R Package: HapSelect. https://doi.org/10.64898/2026.07.08.737160

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗